Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan S Zager

Showing results (211-220 of 247) with videos related to

Pageof 25
Sort By:
Cancer Control : Journal of the Moffitt Cancer Center|November 9, 2021
Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival AnalysisAvani M Kolla, Gerardo A Vitiello, Erica B Friedman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 14, 2011
NCCN Clinical Practice Guidelines Occult primaryDavid S Ettinger, Mark Agulnik, Justin M M Cates, et al.
Annals of Surgical Oncology|November 14, 2018
Microsatellitosis in Patients with MelanomaGiorgos C Karakousis, Phyllis A Gimotty, Stanley P Leong, et al.
The British Journal of Surgery|April 17, 2025
External validation of a model to predict recurrence-free and melanoma-specific survival for patients with melanoma after sentinel node biopsyRobert C Stassen, Carolien C H M Maas, Stanley P Leong, et al.
Annals of Surgical Oncology|July 22, 2022
An Internally Validated Prognostic Risk-Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell CarcinomaAdrienne B Shannon, Richard J Straker, Michael J Carr, et al.
Annals of Surgical Oncology|October 14, 2021
Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional ExperienceMichael J Carr, James Sun, Danielle DePalo, et al.
Annals of Surgical Oncology|April 23, 2021
Predictors of False Negative Sentinel Lymph Node Biopsy in Clinically Localized Merkel Cell CarcinomaRichard J Straker, Michael J Carr, Andrew J Sinnamon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2022
Clinical Outcomes and Risk Stratification of Early-Stage Melanoma Micrometastases From an International Multicenter Study: Implications for the Management of American Joint Committee on Cancer IIIA DiseaseMarc D Moncrieff, Serigne N Lo, Richard A Scolyer, et al.
Annals of Surgical Oncology|October 31, 2025
Recurrence and Survival Outcomes in Patients with Primary Merkel Cell Carcinoma with Positive, Negative, or Not Performed Sentinel Lymph Node BiopsyMichelle M Dugan, Caitlyn Balsay-Patel, Nicholas Chin, et al.
Annals of Surgical Oncology|April 7, 2025
An Open-label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal MelanomaJonathan S Zager, Marlana Orloff, Pier Francesco Ferrucci, et al.
Pageof 25

Showing results (211-220 of 247) with videos related to

Sort By:
Pageof 25
Cancer Control : Journal of the Moffitt Cancer Center|November 9, 2021
Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival AnalysisAvani M Kolla, Gerardo A Vitiello, Erica B Friedman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 14, 2011
NCCN Clinical Practice Guidelines Occult primaryDavid S Ettinger, Mark Agulnik, Justin M M Cates, et al.
Annals of Surgical Oncology|November 14, 2018
Microsatellitosis in Patients with MelanomaGiorgos C Karakousis, Phyllis A Gimotty, Stanley P Leong, et al.
The British Journal of Surgery|April 17, 2025
External validation of a model to predict recurrence-free and melanoma-specific survival for patients with melanoma after sentinel node biopsyRobert C Stassen, Carolien C H M Maas, Stanley P Leong, et al.
Annals of Surgical Oncology|July 22, 2022
An Internally Validated Prognostic Risk-Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell CarcinomaAdrienne B Shannon, Richard J Straker, Michael J Carr, et al.
Annals of Surgical Oncology|October 14, 2021
Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional ExperienceMichael J Carr, James Sun, Danielle DePalo, et al.
Annals of Surgical Oncology|April 23, 2021
Predictors of False Negative Sentinel Lymph Node Biopsy in Clinically Localized Merkel Cell CarcinomaRichard J Straker, Michael J Carr, Andrew J Sinnamon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2022
Clinical Outcomes and Risk Stratification of Early-Stage Melanoma Micrometastases From an International Multicenter Study: Implications for the Management of American Joint Committee on Cancer IIIA DiseaseMarc D Moncrieff, Serigne N Lo, Richard A Scolyer, et al.
Annals of Surgical Oncology|October 31, 2025
Recurrence and Survival Outcomes in Patients with Primary Merkel Cell Carcinoma with Positive, Negative, or Not Performed Sentinel Lymph Node BiopsyMichelle M Dugan, Caitlyn Balsay-Patel, Nicholas Chin, et al.
Annals of Surgical Oncology|April 7, 2025
An Open-label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal MelanomaJonathan S Zager, Marlana Orloff, Pier Francesco Ferrucci, et al.
Pageof 25